Compare DNOW & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNOW | SRPT |
|---|---|---|
| Founded | 1862 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | N/A | 1997 |
| Metric | DNOW | SRPT |
|---|---|---|
| Price | $13.62 | $21.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 29 |
| Target Price | $17.33 | ★ $26.23 |
| AVG Volume (30 Days) | 2.1M | ★ 3.3M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $2,432,000,000.00 | $2,413,715,000.00 |
| Revenue This Year | $21.66 | $13.83 |
| Revenue Next Year | $92.38 | N/A |
| P/E Ratio | $15.73 | ★ N/A |
| Revenue Growth | 3.18 | ★ 47.15 |
| 52 Week Low | $12.01 | $10.42 |
| 52 Week High | $18.45 | $129.84 |
| Indicator | DNOW | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 52.00 |
| Support Level | $13.75 | $20.14 |
| Resistance Level | $14.28 | $22.97 |
| Average True Range (ATR) | 0.41 | 1.29 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 28.82 | 50.96 |
Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies. The Company has three reportable segments being United States, Canada and International.
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.